文献速递细菌感染、耐药与抗菌药物

非妊娠成人侵袭性B族链球菌感染:法国2007-2019年回顾性研究

Invasive group B Streptococcus infections in non-pregnant adults: a retrospective study, France, 2007-2019.
PubMed 文献 · Clin Microbiol Infect · 2020-09-29

该研究基于法国国家链球菌参考中心2007-2019年上报数据,分析1960例非妊娠成人侵袭性B族链球菌(GBS)感染的临床与微生物学特征。结果显示发病中位年龄71岁,以无病灶菌血症为主,脑膜炎在40岁以下患者中更常见;所有分离株对β-内酰胺类敏感,红霉素与克林霉素耐药率保持稳定,氟喹诺酮类敏感性下降逐年上升。

要点

  • 非妊娠成人侵袭性GBS感染以老年人为主,中位发病年龄71岁。
  • 无病灶菌血症是最主要表现,占54.5%。
  • 40岁以下患者脑膜炎比例更高,荚膜III型与CC-17克隆在脑膜炎中富集。

核心结论

  • 非妊娠成人侵袭性GBS感染多见于老年人,临床表现随年龄和GBS型别而异,需持续监测流行病学与耐药趋势。

研究设计与样本

  • 法国国家链球菌参考中心2007-2019年上报的侵袭性GBS感染回顾性研究,共分析1960例非妊娠成人病例。
  • 对全部GBS分离株进行荚膜分型、高毒力CC-17克隆鉴定和药敏试验。
  • 对324株代表性分离株进行多位点序列分型并归入克隆复合群(CC)。

主要发现

  • 发病中位年龄71岁(范围18-103岁)。
  • 主要临床表现为无病灶菌血症,占54.5%。
  • 40岁以下患者脑膜炎更常见:26/180(14.4%)对比78/1780(4.4%),p<0.0001。
  • 荚膜型Ia、Ib、II、III和V合计占91.0%(1786/1960);CC-1、-10、-17、-19和-23合计占96.3%(312/324)。
  • 脑膜炎中荚膜III型占38/104(36.5%,p<0.001),CC-17占22/104(21.2%,p 0.01)。

关键数值与推荐

  • 全部分离株对β-内酰胺类抗生素敏感。
  • 红霉素耐药率32.7%,克林霉素耐药率26.3%,均保持稳定。
  • 氟喹诺酮类敏感性下降逐年增加,2019年达2.7%(趋势p=0.002)。

临床怎么用

  • 提示临床对老年侵袭性GBS感染应警惕无病灶菌血症表现。
  • 年轻患者出现GBS脑膜炎时需关注荚膜III型与CC-17克隆。
  • β-内酰胺类仍是经验性治疗可靠选择,但需关注大环内酯类耐药与氟喹诺酮类敏感性下降。

局限性

  • 为回顾性研究,临床信息来自问卷摘录。
  • 多位点序列分型仅对324株代表性样本开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Group B Streptococcus (GBS) (Streptococcus agalactiae) is a pathogen of growing importance in adults. The objective of this study was to describe the features of invasive infections by GBS in non-pregnant adults. METHODS: GBS infections were reported to the national reference centre for streptococci. Clinical information was abstracted from questionnaires. Capsular typing, identification of the hypervirulent CC-17 clone, and antibiotic susceptibility testing were performed for all GBS isolates. Multi-locus sequence typing and assignment to clonal complexes (CCs) was performed on a representative sample of 324 isolates. RESULTS: In total, 1960 GBS invasive infections were analysed from 2007 to 2019. The median age at onset was 71 years old (range 18-103). The main manifestation was bacteraemia without focus (54.5%). Meningitis was more frequent in patients under 40 (26/180, 14.4% versus 78/1780, 4.4%, p < 0.0001). Capsular types Ia, Ib, II, III and V accounted for 91.0% of the cases (1786/1960). CC-1, -10, -17, -19 and -23 accounted for 96.3% (312/324) of the cases. Capsular type III and CC-17 were overrepresented in meningitis (38/104, 36.5%, p < 0.001 and 22/104, 21.2%, p 0.01, respectively). All isolates were susceptible to β-lactam antibiotics. Resistance to erythromycin (32.7%) and clindamycin (26.3%) remained stable, whereas decreased susceptibility to fluoroquinolones increased, reaching 2.7% in 2019 (p for trend 0.002). CONCLUSIONS: This work highlights the susceptibility of the elderly to GBS infections and differences in the clinical manifestations according to the patients' age and GBS type. In agreement with worldwide reports on emerging multidrug-resistant GBS, it reinforces the need for a continued surveillance of GBS epidemiology.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Vuillemin X, Hays C, Plainvert C, et al. Invasive group B Streptococcus infections in non-pregnant adults: a retrospective study, France, 2007-2019. Clin Microbiol Infect. 2020. PMID: 33007472. doi:10.1016/j.cmi.2020.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。